These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11201371)

  • 1. Clinical features of fulminant hepatitis in Nagasaki Prefecture, Japan.
    Kato Y; Nakata K; Omagari K; Kusumoto Y; Mori I; Furukawa R; Tanioka H; Tajima H; Yano M; Eguchi K
    Intern Med; 2001 Jan; 40(1):5-8. PubMed ID: 11201371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aetiology and prognosis of fulminant viral hepatitis in Japan: a multicentre study. The Study Group of Fulminant Hepatitis.
    Takahashi Y; Shimizu M
    J Gastroenterol Hepatol; 1991; 6(2):159-64. PubMed ID: 1912424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of hepatitis C virus to non-A, non-B fulminant hepatitis in Japan.
    Yoshiba M; Dehara K; Inoue K; Okamoto H; Mayumi M
    Hepatology; 1994 Apr; 19(4):829-35. PubMed ID: 8138253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma exchange therapy in patients with fulminant hepatic failure and limitations of effectiveness.
    Akamatsu K; Tada K
    Prog Clin Biol Res; 1990; 337():239-41. PubMed ID: 2112752
    [No Abstract]   [Full Text] [Related]  

  • 5. An eleven year survey (1975-1985) of fulminant hepatitis: considerations on epidemiology and pathogenesis.
    Scevola D; Barbarini G; Michelone G; Calderon W; Dughetti S
    Boll Ist Sieroter Milan; 1986; 65(6):453-8. PubMed ID: 3107592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple viral infection as the most common cause of fulminant and subfulminant viral hepatitis in an area endemic for hepatitis B: application and limitations of the polymerase chain reaction.
    Wu JC; Chen CL; Hou MC; Chen TZ; Lee SD; Lo KJ
    Hepatology; 1994 Apr; 19(4):836-40. PubMed ID: 8138254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hepatitis C virus infection, 1986-2001: a rare cause of fulminant hepatitis in Chiba, Japan.
    Kanda T; Yokosuka O; Imazeki F; Saisho H
    Hepatogastroenterology; 2004; 51(56):556-8. PubMed ID: 15086201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Present status of fulminant hepatitis in Japan (1989-1991).
    Muto Y
    Gastroenterol Jpn; 1993 Mar; 28 Suppl 4():120-7. PubMed ID: 8486223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Our experience with fulminant hepatic failure in Turkish children: etiology and outcome.
    Aydoğdu S; Ozgenç F; Yurtsever S; Akman SA; Tokat Y; Yağci RV
    J Trop Pediatr; 2003 Dec; 49(6):367-70. PubMed ID: 14725414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fulminant hepatitis: Mayo Clinic experience with 34 cases.
    Rakela J; Lange SM; Ludwig J; Baldus WP
    Mayo Clin Proc; 1985 May; 60(5):289-92. PubMed ID: 3921780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fulminant viral hepatitis.
    Fagan EA; Williams R
    Br Med Bull; 1990 Apr; 46(2):462-80. PubMed ID: 2116214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fulminant hepatic failure.
    Khan JM; Wright RA
    J Ky Med Assoc; 1983 Apr; 81(4):231-4. PubMed ID: 6842059
    [No Abstract]   [Full Text] [Related]  

  • 13. Fulminant hepatitis. An ultrastructural study.
    McCaul TF; Fagan EA; Tovey G; Portmann B; Williams R; Zuckerman AJ
    J Hepatol; 1986; 2(2):276-90. PubMed ID: 3082970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon and cyclosporin A in the treatment of fulminant viral hepatitis.
    Yoshiba M; Sekiyama K; Inoue K; Fujita R
    J Gastroenterol; 1995 Feb; 30(1):67-73. PubMed ID: 7719417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter study on the prognosis of fulminant viral hepatitis: early prediction for liver transplantation.
    Takahashi Y; Kumada H; Shimizu M; Tanikawa K; Kumashiro R; Omata M; Ehata T; Tsuji T; Ukida M; Yasunaga M
    Hepatology; 1994 May; 19(5):1065-71. PubMed ID: 8175127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term trends of the incidence of hepatocellular carcinoma in the Nagasaki prefecture, Japan.
    Taura N; Yatsuhashi H; Nakao K; Ichikawa T; Ishibashi H
    Oncol Rep; 2009 Jan; 21(1):223-7. PubMed ID: 19082466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure.
    Yoshiba M; Inoue K; Sekiyama K; Koh I
    Artif Organs; 1996 Nov; 20(11):1169-72. PubMed ID: 8908326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and prognostic differences in fulminant hepatitis type A, B and non-A non-B.
    Gimson AE; White YS; Eddleston AL; Williams R
    Gut; 1983 Dec; 24(12):1194-8. PubMed ID: 6416935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of autoimmune hepatitis recovered from a fulminant like severe hepatic failure].
    Ohnishi K; Torimoto Y; Ohhira M; Yasuda A; Matsumoto A; Murazumi Y; Mizuno M; Murazumi K; Ohta H; Kohda H
    Nihon Shokakibyo Gakkai Zasshi; 1994 Sep; 91(9):1457-63. PubMed ID: 7933646
    [No Abstract]   [Full Text] [Related]  

  • 20. Present status of hepatitis virus-associated hepatocellular carcinoma in Nagasaki Prefecture, Japan: a cross-sectional study of 1019 patients.
    Tanioka H; Omagari K; Kato Y; Nakata K; Kusumoto Y; Mori I; Furukawa R; Tajima H; Koga M; Yano M; Kohno S
    J Infect Chemother; 2002 Mar; 8(1):64-9. PubMed ID: 11957122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.